bayern Continuing its steady growth in Spain. German pharmaceutical company entered the country 747 million euros with sales in 2022well 7% more Compared to the previous year. Last year’s results relate to the development of all its businesses, expansion plans of some of its headquarters, and the progress and inclusion of new R+ projects, as Bernardo Kanahuati, CEO of Spain and Portugal, explains.
This was stated at a press conference on Thursday. agricultural innovation center Brenes is from Sevilla. It is a center specializing in the development of chemical and biological solutions for plant protection and has an exceptional investment of two million euros in 2022.
However, the agriculture and pharmaceutical company said last February that its operating profits will likely fall globally in 2023. rising costs and reversing the price rise for glyphosate-based herbicides last year.
“Inside a period of great complexity due to geopolitical tensions and inflation, we were able to grow in all our business areas and set a new investment record of up to 72 million euros in the country,” said the CEO. “This has allowed us to expand our manufacturing and innovation capacity while making progress in sustainability and reducing our environmental footprint,” he said.
Bayer has 2,300 employees in Spain from more than 40 nationalities. Globally, the group, which operates in 83 countries, closed 2022 with a turnover of 50.7 billion euros, 8.7% more worldwide.
Your total investment, 29 million corresponds to the improvement of their infrastructure Across the region and the remaining 43 million correspond to investments in research and development projects. “Spain is the number one country in Europe after only the USA for clinical trials,” adds the managing director, citing major researchers and existing clinical centers.
The pharmaceutical field has maintained a steady investment figure by collaborating with more than 700 public and private centers in the country. Agriculture, on the other hand, increased its investment in research and development by more than 19% compared to 2022.
Personal care products reached a remarkable sales figure of 107 million euros with a growth of 15.72 percent.
Among the company’s 2030 targets, It is to reduce by 30%. greenhouse gases and 30% environmental impact plant protection products. The company is also committed to helping 100 million small farmers with innovative practices and providing fertility control methods to women worldwide. On the other hand, reduce irrigation water for rice crops by 25%. “We will face a complex year, but we have launches planned and we aim to be the best possible in the country across all divisions,” the CEO added.
Medications and treatments
Among all its local divisions, “prescription drugs have experienced significant growthAfter recording sales of 390 million euros, this represents an increase of almost 9%,” added Bernardo Kanahuati. These figures are based on the development of cardiovascular therapies and the prevention of age-related ophthalmological diseases for patients with metastatic prostate cancer and Verquvo, worsening heart failure prominent for patients with
Personal care products reached a remarkable number. 107 million Euro sales and 15.72% growth. The CEO explains that the main brands driving this growth in 2022 are GineCanesten, Redoxon and Propalcof.
Bernardo Kanahuati stated that it is understood that “the situation needs to be reviewed in order to improve the access of Spanish patients to innovative medicines” as there is a significant gap compared to other European countries.
Advances in sustainability
The division also continues to advance in its sustainability strategy, which focuses on reducing the environmental impact of its operations and products. Protasio Rodríguez, managing director of Bayer Crop Science Iberia, said, “In 2022, the company will have a really complex context due to price volatility and disruption in the supply chain and numerous global phenomena. In this context, a sales figure of 249 million Euros was achieved in the agriculture division, with an increase of 1.2% compared to 2021.” The company leads the corn seed and plant protection markets.
“The population will increase significantly and there is less and less arable land. In 1960 there was an average of one hectare per capita, and now 1,500 square metres, this is a trend that will accelerate,” adds Rodríguez.
From the Brenes headquarters in Seville, which hosted the event to present the results of the company’s activities in the country, the company seeks to respond to the need to create a more sustainable agriculture and accompany farmers in the transformation to a more sustainable agriculture. Agriculture underlined the managers.